MyAverix Finance
SHE · Healthcare
BGI Genomics Co Ltd (300676)
Diagnostics & Research
BGI Genomics Co Ltd (300676) is listed on SHE in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-28, reported market cap is $16.75B, P/E ratio is 18.00, net margin is -21.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300676
BGI Genomics Co Ltd (300676) — FAQ
What is BGI Genomics Co Ltd's market cap?
BGI Genomics Co Ltd (300676) has a reported market cap of $16.75B (data as of 2026-03-28).
What is 300676's P/E ratio?
The price-to-earnings (P/E) ratio for BGI Genomics Co Ltd (300676) is 18.00 (data as of 2026-03-28).
Does BGI Genomics Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for BGI Genomics Co Ltd (300676). Check the MyAverix Finance app for the latest dividend data.
What sector is BGI Genomics Co Ltd in?
BGI Genomics Co Ltd (300676) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 300676 listed on?
300676 is listed on SHE.
What is BGI Genomics Co Ltd's net margin?
BGI Genomics Co Ltd (300676) reports a net margin of -21.5% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.